Skip to main content
Top
Published in: BMC Nephrology 1/2022

Open Access 01-12-2022 | Nephrotic Syndrome | Research

Haemostatic profile of children with nephrotic syndrome attending University of Nigeria Teaching Hospital Ituku-Ozalla, Nigeria

Authors: Chioma L. Odimegwu, Anthony N. Ikefuna, Henrietta U. Okafor, Theresa Nwagha, Agozie Ubesie, Josephat M. Chinawa

Published in: BMC Nephrology | Issue 1/2022

Login to get access

Abstract

Background

Haemostatic derangements are thought to be due to an imbalance between hepatic synthesis of pro-coagulants and urinary losses of anticoagulants.

Objectives

This study evaluated the coagulation profile of Nigerian children with nephrotic syndrome and examined the relationship between coagulation variables, disease state and steroid responsiveness.

Methods

A cross- sectional hospital based study on evaluation of coagulation profile of children with nephrotic syndrome compared with their age- and gender- matched controls.

Results

The median fibrinogen level in subjects and controls was the same (2.9 g/L). Sixteen of 46 (35%) children with nephrotic syndrome had hyperfibrinogenaemia. The median fibrinogen level of children in remission was 2.3 g/L and differed significantly when compared with those of children in relapse (p = 0.001). The median APTT of children with nephrotic syndrome was 45.0 s and differed significantly compared with those of controls (42.0 s) (p value = 0.02). The median prothrombin time in children with and without nephrotic syndrome were 12.0 and 13.0 s respectively, (p = 0.004). About 90% of children with nephrotic syndrome had INR within reference range. Thrombocytosis was found in 15% of children with nephrotic syndrome. The median platelet count in children with new disease was 432 × 103cells/mm3 and differed significantly when compared with those of controls (p = 0.01).
INR was significantly shorter in children with steroid resistant nephrotic syndrome (SRNS) (median 0.8 s; IQR 0.8 -0.9 s) compared with controls (median 1.0 s; IQR 1.0 -1.1 s) (p = 0.01). Steroid sensitivity was the strongest predictor of remission in children with nephrotic syndrome; steroid sensitive patients were 30 times more likely to be in remission than in relapse (OR 30.03; CI 2.01 – 448.04).

Conclusion

This study shows that the haemostatic derangements in childhood nephrotic involve mostly fibrinogen, APTT, PT, INR and platelet counts. Antithrombin levels are largely unaffected. Variations in fibrinogen, APTT, PT and INR values may be due to the heterogeneous nature of the disease.
Literature
1.
go back to reference Pais P, Avner ED. Nephrotic syndrome. In: Kliegman RM, Stanton BF, III JWSG, Shor NF, editors. Nelson textbook of pediatrics. 19th ed. Philadelphia: Elsevier; 2011. p. 6483–8. Pais P, Avner ED. Nephrotic syndrome. In: Kliegman RM, Stanton BF, III JWSG, Shor NF, editors. Nelson textbook of pediatrics. 19th ed. Philadelphia: Elsevier; 2011. p. 6483–8.
2.
go back to reference Ress L, Brogan P, Bockenhauer D, Webb N. Glomerular disease. In: Ress L, Brogan P, Bockenhauer D, Webb N, editors. Paediatric Nephrology, vol. 9. 2nd ed. Oxford: Oxford University Press; 2012. p. 192. Ress L, Brogan P, Bockenhauer D, Webb N. Glomerular disease. In: Ress L, Brogan P, Bockenhauer D, Webb N, editors. Paediatric Nephrology, vol. 9. 2nd ed. Oxford: Oxford University Press; 2012. p. 192.
3.
go back to reference Wasilewska AM, Zoch-Zwierz WM, Tomaszewska B, Biernacka A. Platelet-derived growth factor and platelet profiles in childhood nephrotic syndrome. Pediatr Nephrol. 2005;20:36–41.CrossRef Wasilewska AM, Zoch-Zwierz WM, Tomaszewska B, Biernacka A. Platelet-derived growth factor and platelet profiles in childhood nephrotic syndrome. Pediatr Nephrol. 2005;20:36–41.CrossRef
4.
5.
go back to reference Kirdpon S, Vuttivirojana A, Kovitangkoon K, Poolsawat SS. The primary nephrotic syndrome in children and histopathologic study. J Med Assoc Thai. 1989;72:17–21. Kirdpon S, Vuttivirojana A, Kovitangkoon K, Poolsawat SS. The primary nephrotic syndrome in children and histopathologic study. J Med Assoc Thai. 1989;72:17–21.
6.
go back to reference Lilova MI, Velkovski IG, Topalov IB. Thromboembolic complications in children with nephrotic syndrome in Bulgaria (1974–1996). Pediatr Nephrol. 2000;15:74–8.CrossRef Lilova MI, Velkovski IG, Topalov IB. Thromboembolic complications in children with nephrotic syndrome in Bulgaria (1974–1996). Pediatr Nephrol. 2000;15:74–8.CrossRef
7.
go back to reference Citak AG, Emre S, Sairin A, Bilge I, Nayır A. Hemostatic problems and thromboembolic complications in nephrotic children. Pediatr Nephrol. 2000;14:138–42.CrossRef Citak AG, Emre S, Sairin A, Bilge I, Nayır A. Hemostatic problems and thromboembolic complications in nephrotic children. Pediatr Nephrol. 2000;14:138–42.CrossRef
8.
go back to reference Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian registry of VTE. Blood. 1994;83:1251–7.CrossRef Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian registry of VTE. Blood. 1994;83:1251–7.CrossRef
9.
go back to reference Kerlin BA, Blatt NB, Fuh B, Zhao S, Lehman A, Blanchong C, et al. Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Paediatric Nephrology Consortium (MWPNC) study. J Pediatr. 2009;155:105–10.CrossRef Kerlin BA, Blatt NB, Fuh B, Zhao S, Lehman A, Blanchong C, et al. Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Paediatric Nephrology Consortium (MWPNC) study. J Pediatr. 2009;155:105–10.CrossRef
10.
go back to reference Eddy AA, Symons JM. Nephrotic syndrome in childhood. The Lancet. 2003;362:629–39.CrossRef Eddy AA, Symons JM. Nephrotic syndrome in childhood. The Lancet. 2003;362:629–39.CrossRef
11.
go back to reference Zhang LJ, Zhang Z, Li SJ, Meinel FG, Nance JW Jr, Zhou CS, et al. Pulmonary embolism and renal vein thrombosis in patients with nephrotic syndrome: prospective evaluation of prevalence and risk factors with CT. Radiology. 2014;273:897–906.CrossRef Zhang LJ, Zhang Z, Li SJ, Meinel FG, Nance JW Jr, Zhou CS, et al. Pulmonary embolism and renal vein thrombosis in patients with nephrotic syndrome: prospective evaluation of prevalence and risk factors with CT. Radiology. 2014;273:897–906.CrossRef
12.
go back to reference Sandoval JA, Sheehan MP, Stonerock CE, Shafique S, Rescorla FJ, Dalsing MC. Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalized children: an increasing population at risk. J Vasc Surg. 2008;47:837–43.CrossRef Sandoval JA, Sheehan MP, Stonerock CE, Shafique S, Rescorla FJ, Dalsing MC. Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalized children: an increasing population at risk. J Vasc Surg. 2008;47:837–43.CrossRef
13.
go back to reference Suri D, Ahluwalia J, Saxena AK, Sodhi KS, Singh P, Mittal BR, et al. Thromboembolic complications in childhood nephrotic syndrome: a clinical profile. Clin Exp Nephrol. 2014;18:803–13.CrossRef Suri D, Ahluwalia J, Saxena AK, Sodhi KS, Singh P, Mittal BR, et al. Thromboembolic complications in childhood nephrotic syndrome: a clinical profile. Clin Exp Nephrol. 2014;18:803–13.CrossRef
14.
go back to reference Sagripanti A, Barsotti G. Hypercoagulability, intraglomerular coagulation and thromboembolism in nephrotic syndrome. Nephron. 1995;70:271–81.CrossRef Sagripanti A, Barsotti G. Hypercoagulability, intraglomerular coagulation and thromboembolism in nephrotic syndrome. Nephron. 1995;70:271–81.CrossRef
15.
go back to reference Llach F. Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int. 1985;28:429–39.CrossRef Llach F. Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int. 1985;28:429–39.CrossRef
16.
go back to reference Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013;35:121–6.CrossRef Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013;35:121–6.CrossRef
17.
go back to reference Pequegnat W, Stover E, Ellen B, Cheryl A. How to Write a Successful Research Grant Application: A Guide for Social and Behavioral Scientists . Springer. 2010. p. 1–420. Pequegnat W,  Stover E, Ellen B, Cheryl A. How to Write a Successful Research Grant Application: A Guide for Social and Behavioral Scientists . Springer. 2010. p. 1–420.
18.
go back to reference Dumville JC, Torgerson DJ, Hewitt CE. Reporting attrition in randomised control trials. BMJ. 2006;332:969–71.CrossRef Dumville JC, Torgerson DJ, Hewitt CE. Reporting attrition in randomised control trials. BMJ. 2006;332:969–71.CrossRef
19.
go back to reference Elidrissy AT, Abdurrahman MB, Bahakim HM, Jones MD, Gader AM. Haemostatic measurements in childhood nephrotic syndrome. Eur J Pediatr. 1991;150:374–8.CrossRef Elidrissy AT, Abdurrahman MB, Bahakim HM, Jones MD, Gader AM. Haemostatic measurements in childhood nephrotic syndrome. Eur J Pediatr. 1991;150:374–8.CrossRef
20.
go back to reference Al-Mugeiren MM, Gader AM, Al-Rasheed SA, Bahakim HM, Al-Momen AK, Al-Salloum A. Coagulopathy of childhood nephrotic syndrome–a reappraisal of the role of natural anticoagulants and fibrinolysis. Haemostasis. 1996;26:304–10.PubMed Al-Mugeiren MM, Gader AM, Al-Rasheed SA, Bahakim HM, Al-Momen AK, Al-Salloum A. Coagulopathy of childhood nephrotic syndrome–a reappraisal of the role of natural anticoagulants and fibrinolysis. Haemostasis. 1996;26:304–10.PubMed
21.
go back to reference Rani AS. A study of PT, APTT, fibrinogen and urinary protein-creatinine ratio in paediatric patients with nephrotic syndrome. Int J Contemp Pediatr. 2014;1:89–93.CrossRef Rani AS. A study of PT, APTT, fibrinogen and urinary protein-creatinine ratio in paediatric patients with nephrotic syndrome. Int J Contemp Pediatr. 2014;1:89–93.CrossRef
22.
go back to reference Asinobi AO, Ademola AD, Okolo CA, Yaria JO. Trends in the histopathology of childhood nephrotic syndrome in Ibadan Nigeria: preponderance of idiopathic focal segmental glomerulosclerosis. BMC Nephrol. 2015;16:213.CrossRef Asinobi AO, Ademola AD, Okolo CA, Yaria JO. Trends in the histopathology of childhood nephrotic syndrome in Ibadan Nigeria: preponderance of idiopathic focal segmental glomerulosclerosis. BMC Nephrol. 2015;16:213.CrossRef
23.
go back to reference Dossier C, Lapidus N, Bayer F, Sellier-Leclerc AL, Boyer O, de Pontual L, et al. Epidemiology of idiopathic nephrotic syndrome in children: endemic or epidemic? Pediatr Nephrol. 2016;31:2299–308.CrossRef Dossier C, Lapidus N, Bayer F, Sellier-Leclerc AL, Boyer O, de Pontual L, et al. Epidemiology of idiopathic nephrotic syndrome in children: endemic or epidemic? Pediatr Nephrol. 2016;31:2299–308.CrossRef
24.
go back to reference Wong W. Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after twelve-month follow-up: results of a three-year national surveillance study. J Paediatr Child Health. 2007;43:337–41.CrossRef Wong W. Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after twelve-month follow-up: results of a three-year national surveillance study. J Paediatr Child Health. 2007;43:337–41.CrossRef
25.
go back to reference El Bakkali L, Rodrigues Pereira R, Kuik DJ, Ket JC, van Wijk JA. Nephrotic syndrome in The Netherlands: a population-based cohort study and a review of the literature. Pediatr Nephrol. 2011;26:1241–6.CrossRef El Bakkali L, Rodrigues Pereira R, Kuik DJ, Ket JC, van Wijk JA. Nephrotic syndrome in The Netherlands: a population-based cohort study and a review of the literature. Pediatr Nephrol. 2011;26:1241–6.CrossRef
26.
go back to reference Kaddah A, Sabry S, Emil E, El-Refaey M. Epidemiology of primary nephrotic syndrome in Egyptian children. J Nephrol. 2012;25:732–7.CrossRef Kaddah A, Sabry S, Emil E, El-Refaey M. Epidemiology of primary nephrotic syndrome in Egyptian children. J Nephrol. 2012;25:732–7.CrossRef
27.
go back to reference Okoro BA, Okafor HU. Pattern of Childhood Renal Disorders in Enugu. Niger J Paediatr. 1999;26:14–8. Okoro BA, Okafor HU. Pattern of Childhood Renal Disorders in Enugu. Niger J Paediatr. 1999;26:14–8.
28.
go back to reference Etuk IS, Anah MU, Ochighs SO, Eyong M. Pattern of paediatric renal disease in inpatients in Calabar. Nigeria Sage J. 2006;4:256–256. Etuk IS, Anah MU, Ochighs SO, Eyong M. Pattern of paediatric renal disease in inpatients in Calabar. Nigeria Sage J. 2006;4:256–256.
29.
go back to reference Mittal A, Aggarwal KC, Saluja S, Aggarwal A, Sureka B. Platelet functions and coagulation changes in Indian children with nephrotic syndrome. J Clin Diagn Res. 2013 ;7(8):1647–50. Mittal A, Aggarwal KC, Saluja S, Aggarwal A, Sureka B. Platelet functions and coagulation changes in Indian children with nephrotic syndrome. J Clin Diagn Res. 2013 ;7(8):1647–50.
30.
go back to reference Anand NK, Chand G, Talib VH, Chellani H, Pande J. Hemostatic profile in nephrotic syndrome. Indian Pediatr. 1996;33:1005–12.PubMed Anand NK, Chand G, Talib VH, Chellani H, Pande J. Hemostatic profile in nephrotic syndrome. Indian Pediatr. 1996;33:1005–12.PubMed
31.
go back to reference Kerlin BA, Haworth K, Smoyer WE. Venous thromboembolism in pediatric nephrotic syndrome. Pediatr Nephrol. 2014;29:989–97.CrossRef Kerlin BA, Haworth K, Smoyer WE. Venous thromboembolism in pediatric nephrotic syndrome. Pediatr Nephrol. 2014;29:989–97.CrossRef
32.
go back to reference Wygledowska G, Grygalewicz J, Matuszewska E. Natural coagulation inhibitors; antithrombin III, protein C, protein S in children with hypercoagulation due to nephrotic syndrome. Med Wieku Rozwoj. 2001;5:377–88.PubMed Wygledowska G, Grygalewicz J, Matuszewska E. Natural coagulation inhibitors; antithrombin III, protein C, protein S in children with hypercoagulation due to nephrotic syndrome. Med Wieku Rozwoj. 2001;5:377–88.PubMed
33.
go back to reference Kerlin BA, Waller AP, Sharma R, Chanley MA, Nieman MT, Smoyer WE. Disease severity correlates with thrombotic capacity in experimental nephrotic syndrome. J Am Soc Nephrol. 2015;26:3009–19.CrossRef Kerlin BA, Waller AP, Sharma R, Chanley MA, Nieman MT, Smoyer WE. Disease severity correlates with thrombotic capacity in experimental nephrotic syndrome. J Am Soc Nephrol. 2015;26:3009–19.CrossRef
34.
go back to reference Duarte RR, Mughal TI, Al-Rogi A. Blood Coagulation and the Nephrotic Syndrome: Deficiency or Excess? Ann Saudi Med. 1990;10:187–93.CrossRef Duarte RR, Mughal TI, Al-Rogi A. Blood Coagulation and the Nephrotic Syndrome: Deficiency or Excess? Ann Saudi Med. 1990;10:187–93.CrossRef
37.
go back to reference Gibbs NM, Gibbs SV. Misuse of ‘trend’ to describe ‘almost significant’ differences in anaesthesia research. BJA. 2015;115:337–9.CrossRef Gibbs NM, Gibbs SV. Misuse of ‘trend’ to describe ‘almost significant’ differences in anaesthesia research. BJA. 2015;115:337–9.CrossRef
38.
go back to reference Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P, et al. Steroid-sensitive nephrotic syndrome: from childhood to adulthood. Am J Kidney Dis. 2003;41:550–7.CrossRef Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P, et al. Steroid-sensitive nephrotic syndrome: from childhood to adulthood. Am J Kidney Dis. 2003;41:550–7.CrossRef
39.
go back to reference Rees L, Greene SA, Adlard P, Jones J, Haycock GB, Rigden SP, et al. Growth and endocrine function in steroid sensitive nephrotic syndrome. Arch Dis Child. 1988;63:484–90.CrossRef Rees L, Greene SA, Adlard P, Jones J, Haycock GB, Rigden SP, et al. Growth and endocrine function in steroid sensitive nephrotic syndrome. Arch Dis Child. 1988;63:484–90.CrossRef
40.
go back to reference Ksiek J, Wyszyska T. Short versus long initial prednisone treatment in steroid-sensitive nephrotic syndrome in children. Acta Paediatr. 1995;84:889–93.CrossRef Ksiek J, Wyszyska T. Short versus long initial prednisone treatment in steroid-sensitive nephrotic syndrome in children. Acta Paediatr. 1995;84:889–93.CrossRef
Metadata
Title
Haemostatic profile of children with nephrotic syndrome attending University of Nigeria Teaching Hospital Ituku-Ozalla, Nigeria
Authors
Chioma L. Odimegwu
Anthony N. Ikefuna
Henrietta U. Okafor
Theresa Nwagha
Agozie Ubesie
Josephat M. Chinawa
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2022
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-022-02894-5

Other articles of this Issue 1/2022

BMC Nephrology 1/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.